EP1203013A4 - Kinase blocking polypeptides and uses thereof - Google Patents
Kinase blocking polypeptides and uses thereofInfo
- Publication number
- EP1203013A4 EP1203013A4 EP00948960A EP00948960A EP1203013A4 EP 1203013 A4 EP1203013 A4 EP 1203013A4 EP 00948960 A EP00948960 A EP 00948960A EP 00948960 A EP00948960 A EP 00948960A EP 1203013 A4 EP1203013 A4 EP 1203013A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- blocking polypeptides
- kinase blocking
- kinase
- polypeptides
- blocking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14490399P | 1999-07-21 | 1999-07-21 | |
US144903P | 1999-07-21 | ||
PCT/US2000/020254 WO2001007466A1 (en) | 1999-07-21 | 2000-07-21 | Kinase blocking polypeptides and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1203013A1 EP1203013A1 (en) | 2002-05-08 |
EP1203013A4 true EP1203013A4 (en) | 2004-10-13 |
Family
ID=22510665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00948960A Withdrawn EP1203013A4 (en) | 1999-07-21 | 2000-07-21 | Kinase blocking polypeptides and uses thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1203013A4 (en) |
JP (1) | JP2003505064A (en) |
AU (1) | AU6237700A (en) |
CA (1) | CA2379863A1 (en) |
WO (1) | WO2001007466A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008501620A (en) * | 2003-09-30 | 2008-01-24 | エンカム ファーマシューティカルズ アクティーゼルスカブ | Methods for regulating cell survival, differentiation and / or synaptic plasticity |
US7713973B2 (en) | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
SG175609A1 (en) | 2006-10-09 | 2011-11-28 | Takeda Pharmaceutical | Kinase inhibitors |
-
2000
- 2000-07-21 AU AU62377/00A patent/AU6237700A/en not_active Abandoned
- 2000-07-21 JP JP2001512549A patent/JP2003505064A/en active Pending
- 2000-07-21 EP EP00948960A patent/EP1203013A4/en not_active Withdrawn
- 2000-07-21 WO PCT/US2000/020254 patent/WO2001007466A1/en not_active Application Discontinuation
- 2000-07-21 CA CA002379863A patent/CA2379863A1/en not_active Abandoned
Non-Patent Citations (3)
Title |
---|
HAKE L E ET AL: "Specificity of RNA binding by CPEB: requirement for RNA recognition motifs and a novel zinc finger.", MOLECULAR AND CELLULAR BIOLOGY. FEB 1998, vol. 18, no. 2, February 1998 (1998-02-01), pages 685 - 693, XP002288823, ISSN: 0270-7306 * |
See also references of WO0107466A1 * |
STEBBINS-BOAZ B ET AL: "CPEB controls the cytoplasmic polyadenylation of cyclin, Cdk2 and c-mos mRNAs and is necessary for oocyte maturation in Xenopus", EMBO JOURNAL 1996 UNITED KINGDOM, vol. 15, no. 10, 1996, pages 2582 - 2592, XP001182610, ISSN: 0261-4189 * |
Also Published As
Publication number | Publication date |
---|---|
AU6237700A (en) | 2001-02-13 |
WO2001007466A1 (en) | 2001-02-01 |
JP2003505064A (en) | 2003-02-12 |
EP1203013A1 (en) | 2002-05-08 |
CA2379863A1 (en) | 2001-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0102535A3 (en) | Cd19xcd3 specific polypeptides and uses thereof | |
HUP0203430A3 (en) | Quinazolinones and their use | |
HRP20060251B1 (en) | Substituted oxasolidinones and their use | |
AU3651002A (en) | Seed-preferred regulatory elements and uses thereof | |
HRP20020375A2 (en) | Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof | |
PL377119A1 (en) | Tacis and br3 polypeptides and uses thereof | |
HUP0301230A3 (en) | Phenylpyridazine derivatives and drugs containing the same | |
GB9809143D0 (en) | Triazine compounds and their use | |
HUP0203896A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof | |
IL153568A (en) | Novel polypeptides and polynucleotides | |
EP1210084A4 (en) | Pyridomorphinans, thienomoprhinans and use thereof | |
IL159872A0 (en) | Gmg-2 polypeptides and their use | |
GB0023323D0 (en) | Arylhydantoin derivatives and uses thereof | |
IL131707A0 (en) | Acetylcholinesterase-derived peptides and uses thereof | |
AU5994599A (en) | Rbp1 polypeptides and uses thereof | |
EP1203013A4 (en) | Kinase blocking polypeptides and uses thereof | |
EP1241257A4 (en) | Novel tachykinin-like polypeptides and use thereof | |
EP1229913A4 (en) | Substituted 1-benzazepines and derivatives thereof | |
GB9917165D0 (en) | Polypeptides polynuclcotides and uses thereof | |
GB9906330D0 (en) | Integrated tail-lift and ramp | |
AU5719501A (en) | Novel human kinase proteins and polynucleotides encoding the same | |
GB9920000D0 (en) | Polypeptides | |
AU6534301A (en) | Phosphorylated polypeptides and uses related thereto | |
AU2001285326A1 (en) | Human kinase proteins and polynucleotides encoding the same | |
AU2001294267A1 (en) | Survivin-like polypeptides and dnas thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020215 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040831 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20041113 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1046533 Country of ref document: HK |